Free Trial
OTCMKTS:PHMMF

Pharma Mar (PHMMF) Stock Price, News & Analysis

Pharma Mar logo
$75.00
0.00 (0.00%)
(As of 11/1/2024 ET)

About Pharma Mar Stock (OTCMKTS:PHMMF)

Key Stats

Today's Range
$75.00
$75.00
50-Day Range
$34.26
$75.00
52-Week Range
$26.85
$75.00
Volume
N/A
Average Volume
34 shs
Market Capitalization
$1.35 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

Pharma Mar Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
3rd Percentile Overall Score

PHMMF MarketRank™: 

Pharma Mar scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Book Value per Share Ratio

    Pharma Mar has a P/B Ratio of 6.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.07% of the outstanding shares of Pharma Mar have been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma Mar has a short interest ratio ("days to cover") of 123, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pharma Mar has recently decreased by 30.90%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pharma Mar does not currently pay a dividend.

  • Dividend Growth

    Pharma Mar does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the outstanding shares of Pharma Mar have been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma Mar has a short interest ratio ("days to cover") of 123, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pharma Mar has recently decreased by 30.90%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Pharma Mar has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Pharma Mar this week, compared to 0 articles on an average week.
Receive PHMMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter.

PHMMF Stock News Headlines

PHMMF Pharma Mar, S.A.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Mar-a-lago
See More Headlines

PHMMF Stock Analysis - Frequently Asked Questions

Pharma Mar's stock was trading at $46.26 at the start of the year. Since then, PHMMF shares have increased by 62.1% and is now trading at $75.00.
View the best growth stocks for 2024 here
.

Shares of PHMMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:PHMMF
Previous Symbol
NASDAQ:PHMMF
CIK
N/A
Employees
509
Year Founded
1986

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$171.15 million
Cash Flow
$0.41 per share
Book Value
$11.62 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.46

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:PHMMF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners